NCT00386828View on ClinicalTrials.gov

Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Advanced Colorectal Cancer

Interventions

DRUG

Bevacizumab:

Trial Locations (6)

Unknown

Tom Baker Cancer Centre, Calgary

BCCA - Centre for Southern Interior, Kelowna

CancerCare Manitoba, Winnipeg

Sunnybrook Odette Cancer Centre, Toronto

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

BC Cancer Agency - Vancouver Centre, Vancouver

All Listed Sponsors

lead

British Columbia Cancer Agency

OTHER

NCT00386828 - Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | Biotech Hunter | Biotech Hunter